Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria

Acta Derm Venereol. 2018 Apr 16;98(4):446-448. doi: 10.2340/00015555-2886.
No abstract available

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Anti-Allergic Agents / adverse effects
  • Anti-Allergic Agents / therapeutic use*
  • Chronic Disease
  • Drug Therapy, Combination
  • Female
  • Histamine H1 Antagonists, Non-Sedating / adverse effects
  • Histamine H1 Antagonists, Non-Sedating / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Omalizumab / adverse effects
  • Omalizumab / therapeutic use*
  • Prospective Studies
  • Recurrence
  • Remission Induction
  • Time Factors
  • Treatment Outcome
  • Urticaria / diagnosis
  • Urticaria / drug therapy*
  • Urticaria / immunology

Substances

  • Anti-Allergic Agents
  • Histamine H1 Antagonists, Non-Sedating
  • Omalizumab